| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A middle-aged woman with acute onset of fever, altered mental status, and movement disorder
|
Kajihara, Yusaku
|
|
|
82 |
C |
p. 116-117
|
artikel
|
| 2 |
Atypical chest pain with precordial T wave inversions
|
Weston, Leah
|
|
|
82 |
C |
p. 112-113
|
artikel
|
| 3 |
Bowel resection reduces aortic pulse wave velocity in patients with ulcerative colitis. A longitudinal study
|
Zanoli, Luca
|
|
|
82 |
C |
p. 126-127
|
artikel
|
| 4 |
Bright liver: a surprise discovery
|
Murakami, Daisuke
|
|
|
82 |
C |
p. 118-119
|
artikel
|
| 5 |
Cause of death and risk factors for mortality in AA amyloidosis: A French retrospective study
|
Terré, Alexandre
|
|
|
82 |
C |
p. 130-132
|
artikel
|
| 6 |
Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration
|
Boriani, Giuseppe
|
|
|
82 |
C |
p. 97-104
|
artikel
|
| 7 |
Definition of tachycardia for risk stratification of pulmonary embolism
|
Hobohm, Lukas
|
|
|
82 |
C |
p. 76-82
|
artikel
|
| 8 |
Disturbance of consciousness after postpartum hemorrhage
|
Tanitame, Keizo
|
|
|
82 |
C |
p. 114-115
|
artikel
|
| 9 |
Does hydroxychloroquine reduce mortality for COVID-19?
|
GALLUS, Silvano
|
|
|
82 |
C |
p. 21-22
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
82 |
C |
p. i
|
artikel
|
| 11 |
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries
|
Cohen, Alexander T.
|
|
|
82 |
C |
p. 48-55
|
artikel
|
| 12 |
Healthy and non healthy obese patients. The truth lies in the adipose tissue
|
Sanidas, E.
|
|
|
82 |
C |
p. 133-134
|
artikel
|
| 13 |
Hydroxychloroquine for COVID-19: Balancing contrasting claims
|
Horby, Peter W.
|
|
|
82 |
C |
p. 25-26
|
artikel
|
| 14 |
Hypertension guidelines: Managing the differences or the patients?
|
Manolis, AJ
|
|
|
82 |
C |
p. 16-17
|
artikel
|
| 15 |
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
|
Centola, Marco
|
|
|
82 |
C |
p. 62-67
|
artikel
|
| 16 |
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis
|
Labenz, Christian
|
|
|
82 |
C |
p. 83-89
|
artikel
|
| 17 |
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
|
Roncon, Loris
|
|
|
82 |
C |
p. 29-37
|
artikel
|
| 18 |
Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
|
Cavalli, Giulio
|
|
|
82 |
C |
p. 23-24
|
artikel
|
| 19 |
Long-term effects of non-retrieved inferior vena cava filters on recurrences of venous thromboembolism in cancer and non-cancer patients: From the COMMAND VTE registry
|
Takase, Toru
|
|
|
82 |
C |
p. 90-96
|
artikel
|
| 20 |
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort
|
Guo, Yutao
|
|
|
82 |
C |
p. 105-111
|
artikel
|
| 21 |
Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation
|
Toma, Matteo
|
|
|
82 |
C |
p. 128-129
|
artikel
|
| 22 |
Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study
|
Mikolasevic, I
|
|
|
82 |
C |
p. 68-75
|
artikel
|
| 23 |
Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences
|
Gressenberger, Paul
|
|
|
82 |
C |
p. 120-122
|
artikel
|
| 24 |
Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy
|
Angeli, Fabio
|
|
|
82 |
C |
p. 123-125
|
artikel
|
| 25 |
The CHA2DS2-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?
|
Fumagalli, Stefano
|
|
|
82 |
C |
p. 56-61
|
artikel
|
| 26 |
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations
|
Verdecchia, Paolo
|
|
|
82 |
C |
p. 1-6
|
artikel
|
| 27 |
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
|
Porcari, Aldostefano
|
|
|
82 |
C |
p. 7-15
|
artikel
|
| 28 |
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
|
|
|
|
82 |
C |
p. 38-47
|
artikel
|
| 29 |
Utilize the full potential of real world evidence
|
Bauersachs, Rupert
|
|
|
82 |
C |
p. 27-28
|
artikel
|
| 30 |
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management
|
Giustozzi, Michela
|
|
|
82 |
C |
p. 18-20
|
artikel
|
Tijdschrift beschrijving